Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review

KARA, MURAT; GUREL, ALI; ELKİRAN TAMER, Emin; AYGEN, Bilge

Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review

Ali GÜREL, (Fırat Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Elazığ, Türkiye)

Bilge AYGEN, (Fırat Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Elazığ, Türkiye)

Murat KARA, (Muğla Üniversitesi, Tıp Fakültesi, Tıbbi Genetik Anabilim Dalı, Muğla, Türkiye)

Emin ELKİRAN TAMER (İnönü Üniversitesi, Tıp, Fakültesi, Tıbbi Onkoloji, Malatya, Türkiye)

Van Tıp Dergisi

2 2

Yıl: 2015 Cilt: 22 Sayı: 3 Sayfa Aralığı: 194 - 196 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review

Öz:

Meme kanseri kadınlarda en sık görülen kanser türüdür. Multipl myelom ise tek hücre tipi kökenli plazma hücrelerinin aşırı çoğalması karakterli bir hastalıktır. Literatürde kemoterapiye ikincil bir çok malignite bildirilmiştir. Sunduğumuz olguda kemoterapi ve radyoterapi sonrası remisyon sağlanmıştır. İskelet sistemi ile ilgili yakınmaları nedeniyle değerlendirilen olguya multipl myelom tanısı konup, ve kemik iliği nakli planlanmıştır. Bu olguyu meme kanseri nedeniyle verilen kemoterapi sonrasında multipl myelom tanısı konması ve antineoplastik ilaç uygulaması dışında başka herhangi bir etyolojik faktör saptanmaması nedeniyle sunmaktayız.

Anahtar Kelime:

Konular: Cerrahi

Meme Kanseri için Verilen Kemoterapi Sonrası Gelişen Multipl Myelom: Vaka Takdimi ve Kısa Bir Derleme

Öz:

Breast cancer is the most common cancer of women. Multiple myeloma is characterized by monoclonal proliferation of plasma cells. There are malignancies secondary to chemotherapy and it has long been recognized. We describe a woman presented with breast cancer and after chemotherapy and radiotherapy she had achieved remission. Because of complaints about skeletal discomfort we reevaluated the patient and diagnosed multiple myeloma and decided to treat with chemotherapy and bone marrow transplantation. In this case we determined multiple myeloma after the administration of chemotherapy for breast cancer and there was not another etiologic factor except antineoplastic agent administration.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık

1. Sinn HP, Kreipe H. A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care (Basel) 2013; 8(2):149-154.
2. Bartsch R, Steger GG. Adjuvant chemotherapy in breast cancer. Memo 2008; 1:91-98.
3. Facts and Figures 2005. ACS 2005:9-11.
4. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56(2):106-130.
5. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 352(9132):930-942.
6. Grosbois B, Decaux O, Azais I, Facon T, AvetLoiseau H. Current treatment strategies for multiple myeloma. Eur J Intern Med 2002; 13(2):85-95.
7. Cömert M, Güneş AE, Sahin F, Saydam G. Quality of Life and Supportive Care in Multiple Myeloma. Turk J Haematol 2013; 30(3):234- 246.
8. Chang HJ, Lee JH, Do YR, Bae SH, Lee JL, Nam SH, et al. A combination of melphalan, prednisone, and 50 mg thalidomide treatment in non-transplant-candidate patients with newly diagnosed multiple myeloma. Korean J Intern Med 2011; 26(4):403-409.
9. Tahan G, Ziauddin MF, Soran A. The role of high risk clinics in screening and managing breast cancer. J Breast Health 2009; 5:167-175.
10. Aranda E. Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007. Clin Transl Oncol 2008; 10:552-559.
11. Öksüzoğlu ÖB. Meme Kanserinde Adjuvan Kemoterapi. Türkiye Klinikleri J Med OncolSpecial Topics 2012; 5(2):47-54.
12. Göksu SS, Coşkun HŞ. Meme Kanseri Tedavisinde Yeni İlaçlar. Türkiye Klinikleri J Med Oncol- Special Topics 2012; 5(2):121-127.
13. Marinopoulos S, Skorda L, Karatapanis S, Rasidakis A. Multiple myeloma emerging after chemotherapy for non-small cell lung cancer. Med Oncol 2008; 25:415-418.
14. Carli PM, Sgro C, Parchin-Geneste N, Isambert N, Mugneret F, Girodon F, et al. Increase therapy-related leukemia secondary to breast cancer. Leukemia 2000; 14(6):1014-1017.
15. Sonneveld P, Kurth KH, Hagemeyer A, Abels J. Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma. Cancer 1990; 65(1):23-25.
16. Wright JD, St Clair CM, Deutsch I, Burke WM, Gorrochurn P, Sun X, et al. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma. Cancer 2010; 116(10):2486-2492.
17. Waller CF, Fetscher S, Lange W. Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer. Leuk Res 1999; 23(10):961-964.

APA	GUREL A, AYGEN B, KARA M, ELKİRAN TAMER E (2015). Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. , 194 - 196.
Chicago	GUREL ALI,AYGEN Bilge,KARA MURAT,ELKİRAN TAMER Emin Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. (2015): 194 - 196.
MLA	GUREL ALI,AYGEN Bilge,KARA MURAT,ELKİRAN TAMER Emin Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. , 2015, ss.194 - 196.
AMA	GUREL A,AYGEN B,KARA M,ELKİRAN TAMER E Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. . 2015; 194 - 196.
Vancouver	GUREL A,AYGEN B,KARA M,ELKİRAN TAMER E Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. . 2015; 194 - 196.
IEEE	GUREL A,AYGEN B,KARA M,ELKİRAN TAMER E "Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review." , ss.194 - 196, 2015.
ISNAD	GUREL, ALI vd. "Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review". (2015), 194-196.

APA	GUREL A, AYGEN B, KARA M, ELKİRAN TAMER E (2015). Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. Van Tıp Dergisi, 22(3), 194 - 196.
Chicago	GUREL ALI,AYGEN Bilge,KARA MURAT,ELKİRAN TAMER Emin Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. Van Tıp Dergisi 22, no.3 (2015): 194 - 196.
MLA	GUREL ALI,AYGEN Bilge,KARA MURAT,ELKİRAN TAMER Emin Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. Van Tıp Dergisi, vol.22, no.3, 2015, ss.194 - 196.
AMA	GUREL A,AYGEN B,KARA M,ELKİRAN TAMER E Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. Van Tıp Dergisi. 2015; 22(3): 194 - 196.
Vancouver	GUREL A,AYGEN B,KARA M,ELKİRAN TAMER E Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review. Van Tıp Dergisi. 2015; 22(3): 194 - 196.
IEEE	GUREL A,AYGEN B,KARA M,ELKİRAN TAMER E "Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review." Van Tıp Dergisi, 22, ss.194 - 196, 2015.
ISNAD	GUREL, ALI vd. "Multiple Myeloma Emerging After Chemotherapy for Breast Cancer: Case Presentation and a Brief Review". Van Tıp Dergisi 22/3 (2015), 194-196.